Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-8

Be carefull in how you interpret that @FreedomInvestor. The outgoings for the last quarter were greatly reduced from 8ish million to 2ish million thanks to a federal goverment R&D tax refund of 6ish million... That wont happen every quarter, so even though the report says 53.6 quarters of funds, its likely closer to 118,000,000 / 7,000,000 = 17 quarters of funds and is more closely aligned with the other statement of funds through and beyond 2025, taking into account the growing expenditure with the expanding clinical trials about to begin.